SOLUTIONS GRADED A++
FDA
Multifaceted governmental agency. In charge of food and drug, also moved on to lab
work in 60's.
In vitro diagnostics
any product, instrument, reagent or system used in diagnosis
FDA General Controls
Misbranding and labeling, GMP (Good Manufacturing Practice)
Class I
i. Least scrutiny
ii. Must be registered
iii. Correct labeling
iv. Efficacy and safety of product
Class II
i. Most common
ii. All the Class I controls
iii. A predicate that has undergone Class III
iv. Documentation of factors different than predicate
v. Method evaluation
Class III
, i. something that is unique and has never been done before, no idea if it's going to work
or not or if safety is up to par
ii. Highest degree of scrutiny
iii. No predicate
iv. Require IDE and PMA
IDE (Investigational Device Exemption)
This is a deal with the FDA -- collaborate with the FDA
No standardize plans
A proposal, investigation plan
Qualifications of investigators, Review of Literature, Completion of IRB, Business plan,
Environmental Impacts, Legal infringements, CLIA complexity
IRB
Internal Review Board - in charge of ethics
PMA (Non-Clinical Aspects)
Analytic performance: Precision, Accuracy, Shelf-life, robustness, toxicology
Pre-analytic variables: Types of specimens, specimen characteristics that may affect
results
PMA (Clinical)
Cllinical trials (All of them go through this) = diagnostic performance, user complexity,
patient feedback
Post Market Surveillance
In the form of an adverse outcomes report --> becomes manufacturer's responsibility to
report adverse outcomes to the FDA